NCT07173517View on ClinicalTrials.gov

Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

Not yet recruitingOBSERVATIONAL
Enrollment

268

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Rechargeable Sacral Neuromodulation DeviceNeurogenic Lower Urinary Tract Dysfunction
Trial Locations (1)

Unknown

Qilu Hospital, Jinan

All Listed Sponsors
collaborator

Aerospace Center Hospital

OTHER

collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

collaborator

Beijing Hospital

OTHER_GOV

collaborator

Xi'an Honghui Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Second Hospital of Jilin University

OTHER

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Tongji Hospital

OTHER

lead

Qilu Hospital of Shandong University

OTHER

NCT07173517 - Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction | Biotech Hunter | Biotech Hunter